Finanical Statements
Glaxo Smith Kline (BIOC.CA) Reports 3 Months Consolidated Results
Published at 17 May 2026 at 12:53Related stock: BIOC
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 31/03/2026
Net Profit : 4,736,899
F/S Consolidated Period : From 01/01/2025 To 31/03/2025
Net Comparative Profit : 59,125,110
Audit Status : Reviewed
Source : Glaxo Smith Kline
The Consolidated Financial Statements in Arabic (6,575 KB)
The Consolidated Financial Statements in English (6,644 KB)
The BoD Report (1,489 KB)
ISIN Code : EGS38171C012
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 31/03/2026
Net Profit : 4,736,899
F/S Consolidated Period : From 01/01/2025 To 31/03/2025
Net Comparative Profit : 59,125,110
Audit Status : Reviewed
Source : Glaxo Smith Kline
The Consolidated Financial Statements in Arabic (6,575 KB)
The Consolidated Financial Statements in English (6,644 KB)
The BoD Report (1,489 KB)